Field dossier · from the corpus
Tumour heterogeneity
0predicted collisions
Where this field is predicted to collide
No open collisions on this field in the current run.
Most cited work
A view on drug resistance in cancer
Concepts of extracellular matrix remodelling in tumour progression and metastasis
Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening
An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity
Patient-Derived Cancer Organoid Cultures to Predict Sensitivity to Chemotherapy and Radiation
Human primary liver cancer organoids reveal intratumor and interpatient drug response heterogeneity